acetylcysteine has been researched along with MS (Multiple Sclerosis) in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Graves, JS; Henry, RG; Mowry, EM; Nourbakhsh, B; Schoeps, VA; Stern, WA; Waubant, E; Zhang, L | 1 |
| Cheraghian, B; Hosseini, SA; Khalatbari Mohseni, G; Majdinasab, N | 1 |
| Arnold, M; Bissinger, R; Lang, F | 1 |
| Agüera, E; Aguilar-Luque, M; Drucker-Colín, R; Escribano, BM; Feijoo, M; Garcia-Maceira, FI; Giraldo, AI; Lillo, R; Luque, E; Medina-Fernández, FJ; Túnez, I; Vieyra-Reyes, P | 1 |
| Boehncke, WH; Elliott, PJ; Zollner, TM | 1 |
| Atlas, D; Barhum, Y; Gilgun-Sherki, Y; Melamed, E; Offen, D | 1 |
| Jana, M; Pahan, K | 1 |
| Khan, M; Pahan, K; Singh, AK; Singh, I | 1 |
| De la Fuente, M; Guaza, C; Hernanz, A; Molina-Holgado, F | 1 |
1 review(s) available for acetylcysteine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Proteasome inhibition: a new anti-inflammatory strategy.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Arthritis, Rheumatoid; Asthma; Boronic Acids; Bortezomib; Clinical Trials as Topic; Cysteine Endopeptidases; Disease Models, Animal; Humans; Inflammation; Lysine; Models, Biological; Models, Chemical; Multienzyme Complexes; Multiple Sclerosis; Neoplasms; NF-kappa B; Peptides; Protease Inhibitors; Proteasome Endopeptidase Complex; Psoriasis; Pyrazines; Reperfusion Injury | 2003 |
2 trial(s) available for acetylcysteine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
N-Acetyl Cysteine as a Neuroprotective Agent in Progressive Multiple Sclerosis (NACPMS) trial: Study protocol for a randomized, double-blind, placebo-controlled add-on phase 2 trial.
Topics: Acetylcysteine; Clinical Trials, Phase II as Topic; Disease Progression; Double-Blind Method; Humans; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Neuroprotective Agents; Randomized Controlled Trials as Topic; Treatment Outcome | 2022 |
Effects of N-acetylcysteine on oxidative stress biomarkers, depression, and anxiety symptoms in patients with multiple sclerosis.
Topics: Acetylcysteine; Anxiety; Biomarkers; Depression; Glutathione; Humans; Multiple Sclerosis; Oxidative Stress | 2023 |
6 other study(ies) available for acetylcysteine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Mitoxantrone-induced suicidal erythrocyte death.
Topics: Acetylcysteine; Annexin A5; Apoptosis; Calcium; Cell Death; Cell Membrane; Cell Size; Ceramides; Erythrocytes; Fluoresceins; Humans; Mitoxantrone; Multiple Sclerosis; Oxidative Stress; Phosphatidylserines; Reactive Oxygen Species | 2014 |
Lipopolysaccharide Binding Protein and Oxidative Stress in a Multiple Sclerosis Model.
Topics: Acetylcysteine; Acute-Phase Proteins; Adult; Animals; Brain; Carrier Proteins; Cell Count; Dasyproctidae; Dimethyl Fumarate; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Lipid Peroxidation; Lipopolysaccharides; Male; Membrane Glycoproteins; Middle Aged; Multiple Sclerosis; Natalizumab; Neurons; Oxidative Stress; Rats; Spinal Cord | 2017 |
Analysis of gene expression in MOG-induced experimental autoimmune encephalomyelitis after treatment with a novel brain-penetrating antioxidant.
Topics: Acetylcysteine; Animals; Antioxidants; Brain; Encephalomyelitis, Autoimmune, Experimental; Gene Expression; Gene Expression Profiling; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin Proteins; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Reactive Oxygen Species; Spinal Cord | 2005 |
Redox regulation of cytokine-mediated inhibition of myelin gene expression in human primary oligodendrocytes.
Topics: Acetylcysteine; Animals; Antioxidants; Cells, Cultured; Cytokines; DNA Primers; Dose-Response Relationship, Drug; Down-Regulation; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression Regulation; Humans; Hydrogen Peroxide; Inflammation; Interleukin-1; Mice; Multiple Sclerosis; Myelin Basic Protein; Myelin Proteins; Myelin Proteolipid Protein; Myelin Sheath; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Neuroglia; Oligodendroglia; Oxidants; Oxidation-Reduction; Phosphoric Diester Hydrolases; Proline; Pyrrolidines; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Sulfhydryl Compounds; Thiocarbamates; Time Factors; Tumor Necrosis Factor-alpha | 2005 |
Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases.
Topics: Acetylcysteine; Adrenoleukodystrophy; Amitrole; Animals; Antioxidants; Apoptosis; Brain; Cells, Cultured; Ceramides; Cytokines; Diamide; DNA Fragmentation; Glutathione; Glutathione Disulfide; Hydrogen Peroxide; Inflammation; Interleukin-1; Multiple Sclerosis; Oxidation-Reduction; Pyrrolidines; Rats; Reactive Oxygen Species; Sphingomyelins; Thiocarbamates; Tumor Necrosis Factor-alpha | 1998 |
N-Acetyl-cysteine inhibition of encephalomyelitis Theiler's virus-induced nitric oxide and tumour necrosis factor-alpha production by murine astrocyte cultures.
Topics: Acetylcysteine; Animals; Animals, Newborn; Astrocytes; Cardiovirus Infections; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Multiple Sclerosis; Nitric Oxide; Nitrites; Theilovirus; Tumor Necrosis Factor-alpha | 1999 |